Kleine Deters, Renee http://orcid.org/0000-0002-6925-4442
Naaijen, Jilly
Holz, Nathalie E.
Banaschewski, Tobias
Schulze, Ulrike M. E.
Sethi, Arjun
Craig, Michael C.
Sagar-Ouriaghli, Ilyas
Santosh, Paramala
Rosa, Mireia
Castro-Fornieles, Josefina
Penzol, María José
Arango, Celso
Brandeis, Daniel
Franke, Barbara
Glennon, Jeffrey C.
Buitelaar, Jan K.
Hoekstra, Pieter J.
Dietrich, Andrea
Funding for this research was provided by:
Seventh Framework Programme (602805, 603016)
Article History
Received: 20 April 2022
Accepted: 4 September 2022
First Online: 20 September 2022
Declarations
:
: T Banaschewski served in an advisory or consultancy role for Actelion, Hexal Pharma, Lilly, Medice, NovartisOxford outcomes, PCM scientific, Shire and Viforpharma. He received conference support or speaker’s fee by Medice, Novartis and Shire. He is/has been involved in clinical trials conducted by Shire & Viforpharma. The present work is unrelated to the grants and relationships noted earlier. U. Schulze received a speaker’s fee from Shire and serves as an unpaid ethics advisor in two EU-funded projects which are not related to the present work. C Arango has been a consultant to or has received honoraria or grants from Acadia, Ambrosseti, Caja Navarra, CIBERSAM, Fundación Alicia Koplowitz, Forum, Instituto de Salud Carlos III, Gedeon Richter, Janssen Cilag, Lundbeck, Merck, Ministerio de Ciencia e Innovación, Ministerio de Sanidad, Ministerio de Economía y Competitividad, Mutua Madrileña, Otsuka, Roche, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovio and Takeda. D Brandeis serves as an unpaid scientific advisor for an EU-funded Neurofeedback trial unrelated to the present work. JC Glennon has acted as a consultant for Boehringer Ingelheim GmbH. B Franke received an educational speaking fee from Medice. JK Buitelaar has been consultant to/member of advisory board of and/or speaker for Janssen Cilag BV, Takeda/Shire, Medice, Angelini, Novartis and Servier. He is not an employee of any of these companies, nor a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents, and royalties. The other authors do not report any biomedical financial interests or potential conflicts of interest.